(2/4)
Half of the world’s insulin (and an increasing amount of the increasingly desirable ozempic) is produced in a small industrial town in Denmark called Kalundborg. The sheer scale of the industry is reflected through the imposition that industry takes upon the site, both in terms of branding, research, and volume of urban presence. A “Kalundborg Symbiosis” brand has emerged, wherein the site’s myriad factories send each other waste materials loudly and proudly, spurring interest from industrialists the world over.